Stocks On the Move: T-Mobile US Inc, Microchip Technology Inc., and Peregrine Pharmaceuticals

TMUS, MCHP, and PPHM are moving sharply in Wednesday's trading

by Andrea Kramer

Published on Oct 15, 2014 at 12:31 PM
Updated on Apr 20, 2015 at 5:32 PM

U.S. stocks are decidedly lower this afternoon, as traders digest a raft of dismal economic data and mounting concerns about Ebola. Among the names making significant moves are telecom concern T-Mobile US Inc (NYSE:TMUS), semiconductor issue Microchip Technology Inc. (NASDAQ:MCHP), and drugmaker Peregrine Pharmaceuticals (NASDAQ:PPHM). Here's a quick look at how TMUS, MCHP, and PPHM are faring on the charts today.

  • TMUS is down 4.7% at $25.16, and earlier tagged a new annual low of $24.50, a day after France's Iliad scrapped its bid for the U.S. carrier. TMUS has underperformed the broader S&P 500 Index (SPX) by nearly 12 percentage points during the past three months, and its 14-day Relative Strength Index (RSI) now sits at 28 -- in oversold territory. Against this backdrop, short-term options players have rarely been more put-biased during the past year, as the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.98 sits just 2 percentage points from a 12-month peak. On the flip side, analysts remain optimistic toward T-Mobile US Inc, as 12 out of 15 brokerage firms have doled out "buy" or better endorsements.

  • MCHP also touched a new low, dropping to $37.44 after rival QUALCOMM, Inc. (NASDAQ:QCOM) dashed its dream of buying CSR Plc. Microchip Technology Inc. shares have surrendered nearly 20% so far this month, after last week gapping lower on an industry warning, and were last seen 1.7% lower at $37.57. The security has underperformed the SPX by more than 17 percentage points during the past 60 sessions, translating into a 14-day RSI of 18 for MCHP. However, not everyone on Wall Street is ruing the stock's fall from grace. Short interest accounts for 11.8% of the shares' total available float, representing nearly 17 sessions' worth of pent-up buying demand, at MCHP's average pace of trading.

  • PPHM -- along with other Ebola-related stocks -- is bucking the trend lower, up 14.3% at $1.60. The company -- which will host its annual shareholder meeting tomorrow -- this morning said it will test its experimental Ebola antibody, and traders are waxing optimistic in light of another confirmed case in Dallas. On a year-to-date basis, Peregrine Pharmaceuticals shares have added more than 15%, yet option buyers have been bracing for the worst. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio of 0.31 stands higher than 99% of all other readings from the past year. In other words, options traders have bought to open PPHM puts over calls at a near-annual-high clip during the past two weeks.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Nevada Discovery That Could Jeopardize Chinese Dominance
Click to continue to advertiser's site.
UNH Stock Pops on Accelerated Payment Promise
Analysts are very bullish on UnitedHealth stock
Extra Space Storage Stock Wavers After Downgrade
Raymond James downgraded to "underperform" from "market perform"
The Top Lithium Play of 2020
Click to continue to advertiser's site.